Investors are liking what they are learning about SignalPath, the two-year-old startup that says its technology represents “research rewired” when talking about clinical trials.

The company has raised $5 million in new capital, according to a securities filing.

Last year, SignalPath raised some $3 million.

So what’s the mission of the company?

“Efficient, effective clinical research accelerates the approval of new treatments, helping patients who are often in dire need. Yet technology has not been adequately leveraged to shrink timelines and decrease costs. To meet the challenge, SignalPath brought together thought leaders, experienced researchers, master clinicians, and technology experts to develop critically needed solutions,” SignalPath says.

Its co-founders both share experiences at Duke University.

Kevin Monroe, who worked at the Duke Clinical Research Institute for 14 years, is the CEO. A NCSU graduate with an MBA from Duke, Monroe says he launched the firm “to develop technology solutions that make clinical research simpler and faster.”

“He has built solutions to meet the needs of everything from large, international studies to individual research units,” SignalPath’s website says.

His company co-founder is Bradford Hersch, a practicing medical oncologist and clinical researcher. He also earned an MBA at Duke and completed his residency and fellowship at the Durham-based university.

Hersch, who is a board member at SignalPath, is also senior medical director at Flatiron Health, which is backed by Google. He lives in Dallas.

Gabriel Gonca;ves, who helped build an analytics software firm that was acquired from Infor, is a board member at SignalPath. He is a principal at Rugula Investments, which is based in Dallas-Fort Worth.

In its latest filing, Signal Path disclosed the first equity sale on Jan. 10 and that all $5 million of the equity offered had been sold by the filing.

According to a form D filed by Evidint LLC, the company offered $1.5 million of equity financing on Oct. 31, 2014. When the form was filed on Nov. 11, 2014, the company had received $500,000, but it was willing to wait a year for the financing.